CLRBZ (CLRBZ) News
Follow CLRBZ (CLRBZ) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Cellectar Biosciences to Report Third-Quarter Results November 10
Cellectar Biosciences plans to report third-quarter financial results and host a conference call on November 10, 2026.
EQUITY | Nov 02, 2026, 01:04 PM UTC
L
Cellectar presents Phase 2b iopofosine data in relapsed/refractory Waldenström macroglobulinemia
Cellectar Biosciences presented efficacy data from a Phase 2b CLOVER WaM subset analysis of iopofosine I 131 in patients relapsed or refractory to BTK inhibitor therapy at the International Workshop for Waldenström Macro
EQUITY | Oct 15, 2026, 11:00 AM UTC
L
Cellectar Biosciences reports Q2 2026 financial results and corporate updates
Cellectar Biosciences (CLRBZ) reports its second-quarter 2026 financial results and provides corporate updates, according to TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 11:15 AM UTC
L
CLRB CLRBW CLRBZ - Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026
CLRB CLRBW CLRBZ - Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026
EARNINGS | Jul 30, 2026, 12:05 PM UTC